The seven world leaders wrapped up their summit in Alberta Tuesday without a unified communique on shared views, which has been the standard after past gatherings.

Using a recent survey on the adoption of AI/ML conducted by the Tufts CSDD as context, pharma leaders discussed how they are using these technologies to optimize trial execution.

While AI can increase efficiency and reduce costs, it can come at the expense of training workers for higher-level roles, ...

Recent analysis explores AI's momentum in drug development, showcasing rapid adoption and significant time savings, despite ...

The ISG State of the Agentic AI Market report findings will be presented at the ISG AI Impact Summit, June 23–24 at the ...

Higher education can navigate AI transformation by prioritizing people, addressing technological change through empathetic ...

Only 18% of respondents in Thailand have adopted artificial intelligence (AI), while 73% are still considering it, citing ...

Background The integration of artificial intelligence (AI) into critical care offers significant potential to enhance early ...

A new Gallup Poll indicates leaders, or "managers of managers," are using AI in the workplace nearly twice as much as ...

GENERATIVE AI is no longer on the sidelines. It's rapidly becoming a core driver of how businesses operate, compete, and ...

While AI is making strides in healthcare, KPMG’s report describes its impact as "more evolutionary than revolutionary".